Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

CVRX.US Logo

CVRX.US - Current Price

$7.31

Company Information

▼
Company Name
CVRx Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US1266381052
CIK: 0001235912
CUSIP: 126638105
Currency: USD
Full Time Employees: 206
Phone: 763 416 2840
Website: https://www.cvrx.com
Fiscal Year End: December
IPO Date: Jun 30, 2021
Description:

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Address:

9201 West Broadway Avenue, Minneapolis, MN, United States, 55445

Directors & Officers

▼
Name Title Year Born
Mr. Kevin Hykes President, CEO & Director 1966
Mr. Jared Oasheim Chief Financial Officer 1983
Mr. Robert Allen John Chief Revenue Officer 1973
Mr. Brent Binkowski Chief Operating Officer NA
Ms. Jonelle R. Burnham VP & General Counsel 1971
Mr. Paul Verrastro Chief Marketing & Strategy Officer 1963
Ms. Tonya A. Austin SPHR Chief Human Resources Officer 1972
Dr. Philip B. Adamson M.D., M.Sc. Chief Medical Officer 1960
Ms. Bonnie Handke M.B.A., R.N. Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics NA

Shares Statistics

▼
Shares Outstanding: 26.21M
Shares Float: 18.10M
% Insiders: 429.50%
% Institutions: 6,492.60%
Short % Float: 6.92%

Valuation Metrics

▼
Enterprise Value: $157.00M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $191.60M
EBITDA: $-49.61M
Book Value: $1.84
Earnings/Share: $-1.99
Profit Margin: -92.95%
Operating Margin: -83.51%
ROA (TTM): -26.34%
ROE (TTM): -91.88%
Revenue (TTM): $55.97M
Revenue/Share (TTM): $2.18
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 9.80%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Mar 31, 2026 0.00 -0.50 N/A 10,000.00%
Dec 31, 2025 0.00 -0.44 N/A 10,000.00%
Sep 30, 2025 -0.49 -0.50 N/A 200.00%
Jun 30, 2025 -0.57 -0.52 N/A -961.54%
Mar 31, 2025 -0.53 -0.57 N/A 701.75%
Dec 31, 2024 -0.43 -0.38 N/A -1,315.79%
Sep 30, 2024 -0.57 -0.47 N/A -2,127.66%
Jun 30, 2024 -0.65 -0.55 N/A -1,818.18%
Mar 31, 2024 -1.04 -0.54 N/A -9,259.26%
Dec 31, 2023 -0.44 -0.54 N/A 1,851.85%
Sep 30, 2023 -0.43 -0.58 N/A 2,586.21%
Jun 30, 2023 -0.56 -0.58 N/A 344.83%
Mar 31, 2023 -0.55 -0.56 N/A 178.57%
Dec 31, 2022 -0.51 -0.56 N/A 892.86%
Sep 30, 2022 -0.48 -0.56 N/A 1,428.57%
Jun 30, 2022 -0.54 -0.53 N/A -188.68%
Mar 31, 2022 -0.49 -0.49 N/A 0.00%
Dec 31, 2021 -0.52 -0.44 N/A -1,818.18%
Sep 30, 2021 -0.30 -0.37 N/A 1,891.89%
Jun 30, 2021 -48.48 -30.49 N/A -5,900.30%
Mar 31, 2021 -0.70 -0.70 N/A 0.00%
Dec 31, 2020 -0.60 0.00 N/A N/A
Dec 31, 2019 -0.21 0.00 N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $105.93M $N/A $133.41M $62.36M $71.06M
2023-12-31 $90.57M $N/A $115.23M $39.28M $75.95M
2022-12-31 $106.19M $N/A $124.94M $15.76M $109.18M
2021-12-31 $142.07M $N/A $152.55M $6.59M $145.96M
2020-12-31 $59.11M $N/A $64.78M $358.02M $-293.24M
2019-12-31 $25.74M $N/A $29.11M $308.15M $-279.04M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 15, 2025 N/A N/A N/A N/A N/A N/A
May 14, 2025 N/A N/A N/A N/A N/A N/A
May 12, 2025 N/A N/A N/A N/A N/A N/A
May 12, 2025 N/A N/A N/A N/A N/A N/A
Nov 19, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist